Emerging research suggests that the microbiome—the collection of microorganisms living in and on our bodies—may play a significant role in cancer development and progression. Certain bacteria have been found to produce metabolites that can either promote or inhibit tumor growth. For instance, Helicobacter pylori is linked to stomach cancer, while some gut bacteria can activate immune responses against tumors. Understanding these interactions could lead to novel preventive and therapeutic strategies.
